Last reviewed · How we verify
Placebo to match PEG-Tα1 — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo to match PEG-Tα1 (Placebo to match PEG-Tα1) — Jiangsu Hansoh Pharmaceutical Co., Ltd.. This is a placebo control formulation designed to match the appearance and administration characteristics of PEG-Tα1 (pegylated thymosin alpha 1) for blinded clinical trial purposes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo to match PEG-Tα1 TARGET | Placebo to match PEG-Tα1 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo to match PEG-Tα1 CI watch — RSS
- Placebo to match PEG-Tα1 CI watch — Atom
- Placebo to match PEG-Tα1 CI watch — JSON
- Placebo to match PEG-Tα1 alone — RSS
Cite this brief
Drug Landscape (2026). Placebo to match PEG-Tα1 — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-to-match-peg-t-1. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab